Indexed on: 24 Jul '20Published on: 23 Jul '20Published in: Journal of contemporary brachytherapy
To investigate the efficacy of percutaneous transhepatic biliary drainage (PTBD) combined with iodine-125 (I) stranded seeds for the treatment of malignant bile duct obstruction (MBO). A retrospective study was performed on 58 consecutive MBO patients. Twenty patients underwent PTBD combined with I stranded seeds (group A). Thirty-eight patients underwent percutaneous trans-hepatic biliary drainage (group B). Total bilirubin, direct bilirubin, and indirect bilirubin levels were compared preoperatively, 1-week, 1-month, and 3-months post-operatively. Carbohydrate antigen 19-9 (CA19-9), cancer antigen 125 (CA125), and carcino-embryonic antigen (CEA) levels were compared at preoperative and 3-month post-operative stages. The time free from biliary obstruction and survival times were compared. The differences in total bilirubin, direct bilirubin, and indirect bilirubin levels between the two groups were not significant preoperatively ( = 0.857, = 0.719, and = 0.870), and 1-week post-operatively ( = 0.259, = 0.395, and = 0.145). However, 1-month ( = 0.012, = 0.005, and = 0.049) and 3-months post-operatively ( < 0.001, = 0.001, and = 0.001), group A was lower than group B. Differences in CA19-9, CA125, and CEA levels between the two groups were not significant preoperatively ( = 0.229, = 0.116, and = 0.273) and 3-months post-operatively ( = 0.159, = 0.342, and = 0.306). The median biliary obstruction free time was 7.0 months for group A and 5.0 months for group B ( < 0.001). The median survival time was 9.0 months for group A and 6.0 months for group B ( = 0.001). PTBD combined with I stranded seeds seem to reduce bilirubin levels and prevents biliary obstruction, promoting survival. Copyright © 2020 Termedia.